Addressing GLP-1 Related Skin Laxity with Sofwave: An FDA Cleared, Non-Invasive Solution for Face and Body The rapid rise in GLP-1 medication has fundamentally shifted the aesthetic treatment landscape. As more patients experience significant and sustained weight loss, practitioners are …
Face the Future announces collaboration
April 23, 2026